SCHEMBL6309768

SCHEMBL6309768

CN(C)CCCc1csc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.53
SLC6A4 P31645 5/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 1/20 0.48
IDO1 P14902 1/20 0.47
SLC6A2 P23975 2/20 0.44
SLC6A3 Q01959 1/20 0.44
CHRNA7 P36544 1/20 0.43
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
PRKCB P05771 1/20 0.41
PRKCA P17252 1/20 0.41
PRKCH P24723 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCD Q05655 1/20 0.41
MTNR1A P48039 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028208 0.90 CYP2A6 (0.56) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL3789614 0.81 CYP2A6 (0.58) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL368354 0.79 CYP2A6 (0.56) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL8290973 0.79 CYP2A6 (0.60) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL25030309 0.79 ALDH1A1 (0.54) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL9347766 0.78 CYP2A6 (0.55) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL9347729 0.78 CYP2A6 (0.55) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL25030035 0.78 CYP2A6 (0.50) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL25029575 0.78 CYP2A6 (0.50) CYP2A6SLC6A4SMN1; SMN2ALDH1A1IDO1
SCHEMBL81236 0.77 CYP2A6 (0.58) CYP2A6SMN1; SMN2ALDH1A1IDO1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844344-B2 Benzofuran derivatives ELI LILLY AND COMPANY (US) 2005-01-18 US disclosed
US-20030232833-A1 Benzofuran derivatives ELI LILLY AND COMPANY 2003-12-18 US disclosed
EP-1246822-A1 BENZOFURAN DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001046177-A1 BENZOFURAN DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232833-A1 Benzofuran derivatives BRD1, BPTF, HTR1F CYP2A6 533/4885SLC6A4 227/4885SMN1; SMN2 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.